Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells-Reference-Cited by-同舟云学术

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

Published:2022-10 Issue:10 Volume:29 Page:1428-1444.e9
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Ferrari Samuele,Jacob Aurelien,Cesana Daniela,Laugel Marianne,Beretta Stefano,Varesi Angelica,Unali Giulia,Conti Anastasia,Canarutto Daniele,Albano Luisa,Calabria Andrea,Vavassori Valentina,Cipriani Carlo,Castiello Maria Carmina,Esposito Simona,Brombin Chiara,Cugnata Federica,Adjali Oumeya,Ayuso Eduard,Merelli Ivan,Villa Anna,Di Micco Raffaella,Kajaste-Rudnitski Anna,Montini Eugenio,Penaud-Budloo Magalie,Naldini Luigi^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference100 articles.

1. Large deletions induced by Cas9 cleavage;Adikusuma;Nature,2018

2. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences;Aurnhammer;Hum. Gene Ther. Methods,2012

3. CRISPR/Cas9 genome editing in human hematopoietic stem cells;Bak;Nat. Protoc.,2018

4. Fitting linear mixed-effects models using lme4;Bates;J. Stat. Softw.,2015

5. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity;Blanchette;J. Virol.,2008

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 -deficient chronic granulomatous disease;Molecular Therapy - Nucleic Acids;2024-09

2. DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome;Molecular Therapy - Methods & Clinical Development;2024-09

3. Adeno-Associated Virus Vectors—a Target of Cellular and Humoral Immunity—are Expanding Their Reach Toward Hematopoietic Stem Cell Modification and Immunotherapies;Human Gene Therapy;2024-08-28

4. Alpharetroviral Vector–Mediated Gene Therapy for IL7RA-Deficient Severe Combined Immunodeficiency;Human Gene Therapy;2024-08-27

5. Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives;Biomolecules;2024-07-15